Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC
Women's Cancer Study Group GmbH
· 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
breast-cancer
breast cancer, hr+/her2- breast cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
#1048144
Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)
#1048145
Magic Camp for Children With Hemiplegic Cerebral Palsy
#1048147
Impact of Different Restorative Treatments for Deep Caries Lesion in Primary Teeth
#1048148
Continuous Lumbar Plexus Block for Postoperative Pain Control After Total Hip Arthroplasty
#1048152
Record
· ID 847363
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.